Stress induced T wave normalization: a new marker of myocardial ischaemia.
Explore the source record for details and available documents.
Biomedical subjects
Publications and source records attributed to P Sellier.
Explore the source record for details and available documents.
The comparison of the anti-ischemic activity of trimetazidine and propranolol was evaluated by multiple end points (clinical, exercise test, and ambulatory electrocardiogram [ECG] monitoring criteria) in 149 male patients with effort angina who received either trimetazidine 20 mg tid or propranolol 40 mg tid during a period of 3 months. The distribution of the standardized differences between the two treatments for each variable was obtained by a permutation method. The medians (estimation of the actual difference between the two treatments) and the 5, 25, 75 and 95% quantiles were represented on the same diagram for all end points. The pattern of the standardized distribution of the differences showed a similar activity of both drugs on symptoms and nitrates consumption, on exercise tolerance and increase in ischemic threshold at exercise, and on ischemia recorded at ambulatory ECG monitoring. Conversely, only propranolol decreased heart rate and rate pressure product at rest as well as at exercise, underlining the difference in the mode of action of the two drugs. This descriptive technique is an attractive method to evaluate the differences between drugs considering multiple criteria favouring the estimation of these differences together with their variability.
The aim of this study was to assess the influence of medical and socioprofessional factors on return to work after myocardial infarction. The authors studied a continuous series of 174 patients with an average age of 51.3 years, all of whom were active before their illness. The average follow-up period was 33 months. One hundred and thirty of the patients (75%) returned to work. The only clinical factors predictive of not returning to work were older age short exercise time and fall in blood pressure on exercise. On the other hand, nearly all socioprofessional factors, social class, type of occupation, size of company, length of employment in their company, physical stresses related to their occupation, were related to return to work. The average time before returning to work was 5.5 +/- 1 month. Though certain immediate criteria of severity of infarction such as previous myocardial infarction or anterior wall infarction were related to a more delayed return to work. The cardiac status evaluated by complementary investigations (left ventricular ejection fraction, exercise testing and Holter monitoring) was not related to the time before return to work. Of the socioprofessional factors, only difficulties related to the patients' work (modification or change of job) were associated with a more delayed return to work. Forty-four patients (33.8%) returned to work after a change in working hours (28 patients), the tasks involved (20 patients) or position (7 patients). Only the lower socioprofessional classes, independent workers and extremes of age could benefit from these measures.
It is well established that a sedentary lifestyle is a risk factor for coronary heart disease. Regular physical activity has a proven beneficial effect in the general population, reducing, in particular, the risk of myocardial infarction. In patients who have had a myocardial infarction, long-term physical exercise at a sufficiently intense level has a beneficial effect on morbidity and mortality. Although there is no statistical proof, it appears that this effect is accompanied by a slight increase in the risk for nonfatal myocardial infarction. The effects of physical activity on other heart diseases are not well known. The mechanisms by which physical exercise exerts its protective effect are not yet well established. Among the proposed hypotheses are the effect on peripheral muscle of physical training, the reduction of myocardial ischemia, and modifications of the adrenergic response to effort and stress. Moreover, physical training has a favorable effect on certain risk factors for coronary heart disease (e.g., lipids profile, arterial hypertension, smoking). The risks involved with physical training in cardiac patients can be evaluated from the data collected from rehabilitation programs. These risks are very slight, provided that the patients are carefully selected.
OBJECTIVES: This study was carried out to determine the effect of the once-daily calcium channel blocking agent amlodipine (half-life 35 to 50 h) on the circadian pattern of myocardial ischemia in patients with chronic stable angina. BACKGROUND: Myocardial ischemia during normal daily life, both symptomatic and asymptomatic, has been associated with increased risk of cardiovascular morbidity and mortality, and the circadian pattern parallels that for myocardial infarction and sudden death. METHODS: The Circadian Anti-Ischemia Program in Europe (CAPE) was a large, 10-week international (63 sites), double-blind, parallel study. After a 2-week, single-blind placebo phase, during which stable doses of antianginal treatment were maintained (beta-adrenergic blocking agents in 65% of patients), patients with chronic stable angina with at least three attacks of angina per week, with at least four ischemic episodes or > or = 20 min of ST segment depression in 48 h of Holter monitoring, were randomized to receive treatment with either 5 mg/day of amlodipine or placebo (2:1 randomization). The dose was increased to 10 mg/day after 4 weeks. During week 7 of treatment, 48-h ambulatory ECG monitoring was repeated. RESULTS: Three hundred fifteen of 1,160 patients screened were eligible, and 250 had complete evaluable data. Compared with placebo, amlodipine significantly reduced both the frequency of ST segment depression episodes (60% for amlodipine vs. 44% for placebo, p = 0.025) and total integrated ST ischemic area (62% mm-min vs. 50% mm-min, p = 0.042). Amlodipine reduced ischemia over the 24 h with the intrinsic circadian pattern maintained. In addition, diary data showed a significant reduction in angina (70% for amlodipine vs. 44% for placebo, p = 0.0001) and in nitroglycerin consumption (67% vs. 22%, respectively, p = 0.0006). Amlodipine and placebo demonstrated similar safety profiles (adverse events 17.3% for amlodipine and 13.3% for placebo; discontinuation rates due to adverse events were 2% vs. 4.4%, respectively). CONCLUSIONS: Once-daily amlodipine, when added to background treatment, significantly reduced both symptomatic and asymptomatic ischemic events over 24 h in patients with chronic stable angina.
1. Trimetazidine has a direct anti-ischaemic effect on the myocardium without altering the rate x pressure product or coronary blood flow. 2. The effects of trimetazidine (20 mg three times daily) were compared with those of propranolol (40 mg three times daily) in a double-blind parallel group multicentre study in 149 men with stable angina. 3. Reproducibility of exercise performance was verified during a 3 week run-in placebo washout period. All patients had > 1 mm ST-depression on exercise test. 4. After 3 months, similar anti-anginal efficacy was observed between the trimetazidine (n = 71) and propranolol (n = 78) groups. No significant differences were observed between trimetazidine and propranolol as regards anginal attack rate per week (mean difference P-TMZ: 2; 95% CI: -4.4, 0.5) and exercise duration (mean difference P-TMZ: 0 s; 95% CI: -33, 34) or time to 1 mm ST segment depression (mean difference P-TMZ: 13 s; 95% CI: -24, 51). Heart rate and rate x pressure product at rest and at peak exercise remained unchanged in the trimetazidine group but significantly decreased with propranolol (P < 0.001 in all cases). With both drugs there was a trend to decreased ischaemic episodes in the 46% patients who experienced ambulatory ischaemia on Holter monitoring. Six patients stopped trimetazidine and 12 propranolol. Of these, five in each group were withdrawn because of deterioration in cardiovascular status. 5. The results suggest that trimetazidine and propranolol at the doses studied have similar efficacy in patients with stable angina pectoris.(ABSTRACT TRUNCATED AT 250 WORDS)
Trimetazidine has been shown to improve anginal symptoms and exercise tolerance in patients with coronary artery disease (CAD). To determine the hemodynamic effects of trimetazidine, systemic hemodynamics were studied in 15 patients suffering from CAD (12 male, 3 female, mean age +/- SEM = 58.6 +/- 1.8 years). Cardiac index was determined by thermodilution method. Left ventricular and aortic pressures were measured using micromanometers (Miller Instruments). After basal measurements, patients were randomly given either placebo (n = 5) or one of two therapeutic doses of trimetazidine 1 mg.kg-1 (n = 5) or trimetazidine 1.5 mg.kg-1 (n = 5) in a double-blind procedure. Data were recorded 5, 10 and 20 min after intravenous drug bolus. Throughout the procedure, the evolution of systemic hemodynamic parameters was not statistically different between the three groups, in particular heart rate, cardiac index, systolic, diastolic and mean aortic pressures, end-diastolic ventricular pressure, mean capillary wedge pressure, pulmonary artery pressures or systemic vascular resistances. We conclude that, unlike other antianginal drugs (particularly beta-blockers, nitrates and calcium-channel inhibitors), trimetazidine does not modify systemic hemodynamics in patients with CAD. These results are consistent with a direct effect of trimetazidine on the ischemic myocardial cell previously reported.
Eight patients with vitamin deficiency pancytopenia were admitted, within a year, in a department of internal medicine. Folic acid and vitamin B12 metabolism and the clinical and haematological symptoms are discussed. These vitamin deficiencies are frequent in underdeveloped countries and are responsible of megaloblastic anaemia. Such deficiencies may also influence the granulocyte and platelet lines and may be mistaken for leukaemia. A therapeutic test may be undertaken, giving rapid diagnosis and avoiding high mortality.
Explore the source record for details and available documents.
Silent myocardial ischaemia (SMI) is a common manifestation of coronary artery disease. Continuous electrocardiographic recordings have shown that 75% of ischemic episodes are asymptomatic. In addition, SMI has the same consequences as symptomatic ischaemia on myocardial perfusion and ventricular function. There are many means of detecting SMI, continuous electrocardiographic monitoring, exercise stress testing with or without methods of analysis of myocardial perfusion or wall motion using radioactive tracers or echocardiography. The latter techniques seem to improve the sensitivity of exercise stress testing. More recently, pharmacological stress testing coupled with myocardial scintigraphy or echocardiography has been introduced. In coronary patients, the prevalence of SMI on Holter monitoring is about 50% in angina and 25% after myocardial infarction. The prognostic value of SMI has been the object of much research. In asymptomatic patients with documented coronary artery disease, SMI is associated with a relative risk of a cardiac event 2 to 3 times greater than that of subjects without ischaemia. In angina pectoris, the relative risk of future cardiac events is 5.3 times greater, and that of death is 2.3 times greater. These results reported with the Holter method have been confirmed by those of exercise stress testing with and without coupled imaging techniques. In unstable angina, the results are the same: the relative risk of cardiac events in patients with SMI on Holter monitoring is increased by a factor of 4.5, and that of death by a factor of 4. This increased risk is also observed after myocardial infarction whether SMI is recorded by Holter monitoring or exercise stress testing. However, these observations are not confirmed in all reports.(ABSTRACT TRUNCATED AT 250 WORDS)
Explore the source record for details and available documents.
A retrospective study of 22 bacteriologically documented cases of tuberculosis associated with HIV1 positivity was carried out in the department of infectious diseases of Marseille, south of France, a high prevalence area for HIV infection. Sixty-seven percent of the patients were intravenous drug abusers. Thirty-two percent were classified as having AIDS prior to the diagnosis of tuberculosis. All but one had M. tuberculosis isolated from bronchopulmonary samples; 5 had no parenchymatous radiological abnormalities, 5 had excavated lesions. Four patients had cervical adenopathies, 4 other patients had asymptomatic extra-pulmonary sites of infection. All patients responded well to chemotherapy; no relapse was observed during or after treatment. Eight died, two of them before treatment (cause of death unknown), 6 from other complications of AIDS within the 2 years following the diagnosis of tuberculosis. The low incidence of extra-thoracic involvement and the high frequency of excavated pulmonary lesions are discordant with most US studies, as is the relatively late onset of tuberculosis in the course of HIV infection. We suggest that different local epidemiological factors and maybe the practice of systematic BCG vaccination during childhood in France could contribute to these differences.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
The present investigation primarily deals with the inheritance of a pigmeat quality trait, the Napole technological yield (RTN), a measure of cooked weight to fresh weight. This trait as well as lean percentage at 100 kg liveweight and fattening length from 20 to 100 kg liveweight were recorded on 3459 offspring from 67 sires and 433 dams, and 3052 offspring from 64 sires and 405 dams in Penshire (P66) and Pen Ar Lan (P77) composite lines respectively. The hypothesis of a major 2-allele locus contributing to RTN was tested by use of a segregation analysis method. Highly significant likelihood ratios (mixed vs. polygenic transmission models) lead us to conclude that a major gene RN- exerting an unfavourable effect on RTN is segregating in both lines. Maximum likelihood estimates of the parameters under the hypothesis of mixed (monogenic + polygenic) inheritance show that the difference between the means of the 2 homozygotes amounts to about 3 phenotypic standard deviations of the trait, whereas the complete dominance of RN- cannot be rejected. The frequency of RN- is about 0.6 in both lines. These results are discussed in connection with the previously reported 'Hampshire effect' on pigmeat quality, as the Hampshire breed is a common component of the foundation stock of the 2 composite lines under study.
Even if the effects of physical training on secondary prevention are controversial, it is known that exercise may influence several of the risk factors for coronary heart disease (CHD). One of the most important is cholesterol. Studies conducted to determine the influence of training on lipid profile have shown in normals, as well as in CHD patients, a favourable influence: a small decrease in total cholesterol and low-density lipoprotein cholesterol, and an increase in high-density lipoprotein cholesterol. These results are obtained after prolonged and intensive training. The influence of training on coagulation is more controversial and less well known. During short bouts of exercise the following changes are generally observed: an increase in platelet count and platelet aggregation (the effects on platelet adhesiveness and activation are controversial), potentiation of coagulation with an increase in factor VIII, and an increase in fibrinolytic activity due to an increase in plasminogen activator level. The effects of training have been less well studied. It is supposed that training could diminish the clotting potentiation observed during short exercise. Fibrinolysis is also increased in these conditions. If the influence of training on blood lipid profile may be considered as favourable in secondary prevention, no study has yet assessed the role of training on coagulation factors in secondary prevention.
The prognostic significance of an early occurrence, or recurrence, of angina pectoris after myocardial infarction was studied in 254 patients (221 male, 33 female; mean age 58 +/- 11 years). During the in-hospital rehabilitation program, 41 patients (16%) had anginal pain. The mean follow-up was 21 months (range 12-33 months). Among the 254 patients, 21 died, five had recurrent myocardial infarction, 13 had unstable angina, and 22 underwent aortocoronary bypass surgery. An early recurrence of angina pectoris was predictive of combined (medical + surgical) events (21 patients, P less than 0.05), medical events (11 patients, P less than 0.05) and surgical events (10 patients, P less than 0.001), but failed to predict individual death (six patients), recurrent myocardial infarction (two patients) or unstable angina (three patients). Of the events that occurred in the 254 patients, 34% were predicted by the early recurrence of angina pectoris. Early post-infarction angina was observed more frequently in older patients and patients with previous history of angina pectoris. This represents an important prognostic factor after myocardial infarction, which defines a high-risk group of patients requiring further investigation and appropriate therapeutic approaches.
A single dose of 60 mg trimetazidine (the normal daily dose) improved exercise capacity in angina pectoris, as reflected by an increase in the duration of exercise, total work performed, and improvement in ECG signs of ischaemia. All these effects occurred without any detectable chronotropic or vasomotor effect. The importance of this study is to demonstrate that these beneficial effects, already well-recognized after chronic administration of 20 mg three times a day, also occur after a single administration equivalent to the normal daily dose.